Literature DB >> 10618141

Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.

B A Odland1, M E Erwin, R N Jones.   

Abstract

This multicenter study proposes antimicrobial susceptibility (MIC and disk diffusion methods) quality control (QC) parameters for seven compounds utilized in veterinary health. Alexomycin, apramycin, tiamulin, tilmicosin, and tylosin were tested by broth microdilution against various National Committee for Clinical Laboratory Standards (NCCLS)-recommended QC organisms (Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212, Streptococcus pneumoniae ATCC 49619, Escherichia coli ATCC 25922, and Pseudomonas aeruginosa ATCC 27853). In addition, disk diffusion zone diameter QC limits were determined for apramycin, enrofloxacin, and premafloxacin by using E. coli ATCC 25922, P. aeruginosa ATCC 27853, and S. aureus ATCC 25923. The results from five or six participating laboratories produced >/=99.0% of MICs and >/=95.0% of the zone diameters within suggested guidelines. The NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing has recently approved these ranges for publication in the next M31 document.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618141      PMCID: PMC88749          DOI: 10.1128/JCM.38.1.453-455.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy?

Authors:  L J Piddock
Journal:  J Antimicrob Chemother       Date:  1996-07       Impact factor: 5.790

2.  Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans?

Authors:  J P Donnelly; A Voss; W Witte; B E Murray
Journal:  J Antimicrob Chemother       Date:  1996-02       Impact factor: 5.790

3.  Premafloxacin: a projected veterinary use fluoro-quinolone with significant activity against multi-resistant gram-positive human pathogens.

Authors:  L Zerva; S A Marshall; R N Jones
Journal:  J Antimicrob Chemother       Date:  1996-10       Impact factor: 5.790

4.  Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones.

Authors:  P C Hannan; G D Windsor; A de Jong; N Schmeer; M Stegemann
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

5.  Are glycopeptide-resistant enterococci in animals a threat to human beings?

Authors:  I Das; A Fraise; R Wise
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

6.  Determination of bacterial susceptibility to tylosin by single-disk agar diffusion tests.

Authors:  M C McDonald; E L Biberstein
Journal:  Am J Vet Res       Date:  1974-12       Impact factor: 1.156

7.  Apramycin, a new aminocyclitol antibiotic. I. In vitro microbiological studies.

Authors:  J R Walton
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

8.  Comparative in vitro activity of alexomycin (U-82127) tested against Escherichia coli, Salmonella spp., and enterococci of animal and human origin.

Authors:  Ronald N. Jones; Yao-Shen Chen; Steven A. Marshall
Journal:  Clin Microbiol Infect       Date:  1998       Impact factor: 8.067

9.  Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin.

Authors:  T R Shryock; D W White; C S Werner; J M Staples
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Tiamulin in the treatment and prophylaxis of experimental swine dysentery.

Authors:  D J Taylor
Journal:  Vet Rec       Date:  1980-06-21       Impact factor: 2.695

View more
  4 in total

1.  Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Alejandro Pironti; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi.

Authors:  Klaus-Peter Hunfeld; Thomas A Wichelhaus; Rebecca Rödel; Georg Acker; Volker Brade; Peter Kraiczy
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Antimicrobial susceptibility testing of porcine Brachyspira (Serpulina) species isolates.

Authors:  M Karlsson; C Fellström; A Gunnarsson; A Landén; A Franklin
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  Wild-type cutoff for Apramycin against Escherichia coli.

Authors:  Yuqi Yang; Tianshi Xiao; Jiarui Li; Ping Cheng; Fulei Li; Hongxiao Yu; Ruimeng Liu; Ishfaq Muhammad; Xiuying Zhang
Journal:  BMC Vet Res       Date:  2020-08-26       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.